Medimaps Group receives CE MDR certification for TBS Reveal™, bringing opportunistic bone-fragility assessment to routine X-rays
17/06/2026 -
Press releases
Medimaps achieves MDSAP certification, strengthening quality management credentials across five major regulatory markets
28/05/2026 -
Media - Press releases
New Study in The Lancet’s eClinicalMedicine Demonstrates Strong Potential for Identifying Bone Fragility Risk from Routine X-Rays
01/05/2026 -
Insights
Osteoporosis Awareness Month 2026: Can DXA alone capture the full picture of fracture risk?
01/03/2026 -
Media - Press releases
Medimaps Group and Radiobotics Announce Strategic Merger to Expand AI-Driven Musculoskeletal Imaging Portfolio
26/01/2026 -
Clinical news
TBS en la Guía Nacional para la Osteoporosis en Colombia
01/12/2025 -
Media - Press releases
Medimaps Group to Unveil TBS Reveal – Opportunistic Screening AI Software on X-Ray – at RSNA
11/11/2025 -
Insights
How the next generation of TBS Osteo: TBS Osteo Advanced is transforming bone health assessment
13/10/2025 -
Clinical news
Role of Trabecular Bone Score in supporting the management of patients with cancer
29/07/2025 -
Media - Press releases
Medimaps Group Collaborates with National Spine Health Foundation to Advance AI-Based Bone Fragility Assessment in Spine Surgery
03/07/2025 -
Media - Press releases
Medimaps Group Launches In Europe TBS Osteo Next-Generation Software For Advanced Bone Microarchitecture Assessment
10/06/2025 -
Media - Press releases
Medimaps Group expands in the U.S. with the launch of TBS Osteo next-generation software for advanced bone microarchitecture assessment
03/06/2025 -
Clinical news
A new publication in Osteoporosis International shows trabecular bone score predicts distal femur screw pull-out strength better than DXA bone mineral density, CT Hounsfield units, and cortical density
14/05/2025 -
Clinical news
Fracture risk in rheumatic diseases: the value of Trabecular Bone Score
13/05/2025 -
Clinical news
TBS included in national guidelines for diagnosis and treatment of osteoporosis in Slovakia
07/05/2025 -
Clinical news
Understanding fracture risk in endocrine disorders: the role of Trabecular Bone Score
01/05/2025 -
Media - Press releases
SimonMed Launches DEXA + TBS: A New Standard for Bone Health
01/05/2025 -
Clinical news
What is the added value of TBS in osteoporosis clinical management?
Medimaps Group is certified to ISO 13485:2016 (certificate C831121). TBS Insight is FDA 510(k) cleared and MDR compliant, CE-marked under notified body 2460.
Please note that you are now accessing content reserved for healthcare professionals only. By accepting, you confirm that you are a healthcare professional.
Click “OK” to confirm you are a Healthcare Professional.